Credit: Canva
Intermittent fasting, a special diet plan which alternates between fasting and eating, has gained popularity for its weight loss effect. Now, new research has indicated that it may mitigate the risk of heart disease, type 2 diabetes and other serious health conditions. The study, published in the Annals of Internal Medicine explores how time-restricted eating (TRE), a form of intermittent fasting, may help individuals with metabolic syndrome manage their condition.
TRE involves consuming calories within a designated window of 8 to 10 hours while fasting for the remaining hours. Outside the eating period, only water, black coffee, or unsweetened tea is permitted. This approach aligns food intake with the body’s natural circadian rhythms, potentially enhancing metabolic function.
At the start of the study, participants’ average eating window was over 14 hours. Those in the TRE group successfully reduced this by four hours. After three months, the TRE group showed significant improvements in hemoglobin A1C (HbA1c) levels, a key marker for blood sugar control. Lowering HbA1c is crucial for reducing the risk of type 2 diabetes.
Additionally, the TRE group experienced weight loss without losing muscle mass, reduced body mass index (BMI), and decreased abdominal fat, all of which contribute to improved metabolic health.
Experts believe that TRE’s benefits stem from its alignment with the body’s circadian rhythms, which regulate metabolism, digestion, and hormonal fluctuations. Restricting food intake to the body’s natural metabolic peaks can lead to improved blood sugar regulation, healthier lipid profiles, and overall better metabolic function.
Moreover, fasting intervals may allow the digestive system to rest and repair, supporting gut health and reducing inflammation. The process also shifts the body towards burning stored fat for energy, promoting weight loss.
© 2024 Bennett, Coleman & Company Limited